Pediatric chronic fatigue syndrome:current perspectives by Crawley, Esther
                          Crawley, E. (2018). Pediatric chronic fatigue syndrome: current perspectives.
Pediatric Health, Medicine and Therapeutics, 9, 27-33.
https://doi.org/10.2147/PHMT.S126253
Publisher's PDF, also known as Version of record
License (if available):
CC BY-NC
Link to published version (if available):
10.2147/PHMT.S126253
Link to publication record in Explore Bristol Research
PDF-document
This is the final published version of the article (version of record). It first appeared online via Dove Press at
https://www.dovepress.com/pediatric-chronic-fatigue-syndrome-current-perspectives-peer-reviewed-article-
PHMT . Please refer to any applicable terms of use of the publisher.
University of Bristol - Explore Bristol Research
General rights
This document is made available in accordance with publisher policies. Please cite only the published
version using the reference above. Full terms of use are available:
http://www.bristol.ac.uk/pure/about/ebr-terms
© 2018 Crawley. This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms. 
php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work 
you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For 
permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
Pediatric Health, Medicine and Therapeutics 2018:9 27–33
Pediatric Health, Medicine and Therapeutics Dovepress
submit your manuscript | www.dovepress.com
Dovepress 
27
R E V I E W
open access to scientific and medical research
Open Access Full Text Article
http://dx.doi.org/10.2147/PHMT.S126253
Pediatric chronic fatigue syndrome: current 
perspectives
Esther Crawley
Centre for Child and Adolescent 
Health, Bristol Medical School, 
University of Bristol, Bristol, UK
Abstract: Pediatric chronic fatigue syndrome is an important illness as it is relatively common 
and also very disabling with a wide range of impacts on the child, the family, and health care 
systems. It is a complicated illness but the majority of children get better with specialist treatment. 
This literature review provides an update on the epidemiology of chronic fatigue syndrome / 
myalgic encephalomyelitis, including factors associated with it, and discusses the current 
evidence for treatment.
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Introduction
What is chronic fatigue syndrome/myalgic 
encephalomyelitis (CFS/ME)?
Children and adolescents with CFS have severe disabling fatigue that lasts for at least 
3 months. They have additional symptoms, including headaches, sleep problems, 
cognitive problems, sore throat, muscle aches and pains, nausea, and dizziness. 
Post-exertional malaise is a core symptom and the most useful when making a 
diagnosis. Children experience an increase in fatigue, malaise and symptoms after 
an increase in exertion. For many, this means they attend 1 or 2 days of school, 
before becoming too unwell to attend school at all. Some children are severely 
affected and post-exertional malaise presents as an increase in symptoms after, 
for example, taking a shower or walking down the stairs. Other symptoms that are 
almost universal in children and adults are cognitive dysfunction and disturbed/
unrefreshing sleep.1,2 Table 1 lists the different clinical and research definitions 
used to define CFS/ME.
Impact of CFS/ME
CFS/ME can have a devastating impact on children in terms of quality of life,5 school, 
social life, and family function6,7 at the crucial time of development. It also has an 
impact on health service provision. Children with CFS/ME have an increase in medical 
consultations, tests, and prescriptions, up to five years before receiving a diagnosis.8 
Most children attending a specialist service attended 40% of school or less.9 About 
one-third of them suffer from comorbid anxiety and/or depression.10,11 Children suffer 
social isolation, give up hobbies, and experience significant pain in addition to their 
fatigue.12
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Epidemiology
Prevalence
Many adolescents have severe fatigue but the prevalence 
of CFS is less common. Between 34% and 41% of adoles-
cents report feeling “much more tired and worn out than 
usual”.13,14 The prevalence of CFS in children and adolescents 
is between 0.11% and 4%.14–19 There are two peaks for CFS, 
one in children and adolescents (10–19 year olds) and one in 
30-year olds.20 The different prevalence rates reflect different 
diagnostic criteria and the different research methodologies 
used to identify cases. Population surveys report higher preva-
lence rates than surveys relying on self-report, or studies that 
recruit participants from clinical settings requiring a clinical 
diagnosis. This may be because patients experience barriers in 
obtaining a diagnosis21 and treatment, which may partly be due 
to the fact that doctors find it difficult to make a diagnosis.22 
Incidence
There is little known about the incidence of pediatric CFS/ME. 
The estimated incidence of pediatrician-diagnosed CFS/ME in 
the Netherlands is 0.01%17 but this is likely to be lower than the 
true incidence as not all children with CFS get a diagnosis.19 
In the UK, an incidence of 0.36% in a 4–6 month window has 
been reported but the number of cases was low (4/1096)23 and 
therefore, the true incidence of CFS/ME remains uncertain.
Factors associated with pediatric CFS/ME
Gender
CFS is equally common in boys and girls aged ≤13 years.2,18,24 
The prevalence then appears to increase in females but not 
males after puberty; so, based on gender, CFS is 2–3 times 
more common in females in older teenagers and adults.
Social adversity
CFS was previously considered to be an illness that only 
affected those of upper socio-economic classes and in the 
1980s, it was nicknamed “yuppie flu”. This may reflect 
successful health-seeking behavior. However, as with many 
chronic illnesses, social adversity is a risk factor for CFS. 
Adversity in pregnancy increases the risk of developing CFS 
in 13 and 16 olds with odds ratios (OR) between 1.10 and 
1.20 per unit family adversity index.14,18
Genetic factors
Twin studies consistently show that genetic factors are 
an important risk factor for CFS. In adults, monozygotic 
(identical) twins have a higher concordance rate compared 
with dizygotic twins. For example, in a study of 146 female–
female twin pairs, a monozygotic correlation of 0.55 was 
reported compared with a dizygotic correlation of 0.19.25 In 
a larger study of 1004 adult twins, the equivalent correlations 
were 0.43 and 0.16, respectively. A large component of the 
genetic variation for fatigue is not shared by other forms 
of distress.26 These correlations in twin studies are higher 
in children than in adults, suggesting that children may be 
more genetically “loaded”, which may explain why they get 
CFS earlier in life.
Maternal mood
Mothers of children with CFS have high levels of comorbid 
mood disorder.7 This could be secondary to the impact this 
illness has on their child and family, which includes: social 
isolation, lack of understanding, marital tension, concern 
about their child’s distress, and loss of earnings.7 However, 
maternal mood in early childhood (pregnancy to age 6) 
increases the risk of developing CFS in adolescence.27 There 
are several possible explanations for this, including: increased 
susceptibility to fatigue because of in utero or early-life 
epigenetic effects; change in activity because of maternal 
mood; and change in questionnaire response because of 
maternal mood and co-segregation of genetic risk factors 
for mood and fatigue.
Table 1 Definitions used to define CFS/ME
Criteria Duration Required symptoms
Oxford (1991)74 ≥6 mo Cognitive dysfunction
CDC, Fukuda (1994)75 ≥6 mo 4 of 8 symptoms concurrently for ≥6 m
NICE (2007)56 ≥4 mo 1 of 10 symptoms listed
ME: ICC3 Not defineda PENE plus 1 symptom from each of neurological, immune/gastrointestinal/genitourinary 
impairment/energy metabolism categories
IOMb (2015)4 ≥6 mo Post-exertional malaise AND sleep disturbance AND cognitive dysfunction AND/OR 
orthostatic intolerance
Notes: aThe authors state “diagnosis should be made when the clinician is satisfied that the patient has ME rather than having the diagnosis restricted by a specified time 
factor”; bsuggested a new name: Systemic Exercise Intolerance Disease (SEID).
Abbreviations: ICC, International Consensus Criteria; IOM, Institute of Medicine; ME, myalgic encephalomyelitis; PENE, post-exertional neuroimmune exhaustion; CDC, 
Centre for Disease Control and Prevention; mo, months; NICE, The National Institute for Health and Care Excellence.
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Infection
Infection is a known risk factor for developing CFS in adults 
and children. The association of CFS with Epstein–Barr 
virus is well described with rates of 13%, 7%, and 4% at 6, 
12, and 24 months, respectively, after infection.28 All types 
of gastrointestinal infections increase the risk of developing 
CFS in adults.29 It seems likely that it is the severity of the 
infection rather than the type of infection that is important.30
Comorbid mood disorders
Up to one-third of children with CFS have significant problems 
with anxiety and/or depression.2,10,11 Anxiety is more common 
in children with CFS/ME compared with those with other 
long-term conditions such as juvenile idiopathic arthritis.31 
Those with low mood are more disabled, have worse fatigue, 
and increased pain compared with those with only CFS.11 
In many cases, depression appears to develop because of 
the impact CFS has on the young person’s life in terms of 
schooling, friendship groups, hobbies, and sport.32–34 They 
describe a sense of loss, restriction in activities, and change 
in their social environments (e.g., negative experiences with 
their peers), which contribute to their low mood.32 However, 
we do not know which comes first in all cases.35 The evidence 
is conflicting on whether depression worsens prognosis36–42 in 
adults, and no data have been found on whether depression 
changes outcome in children.43 But it is plausible that comorbid 
mood disorders may make recovery from CFS/ME less likely.
Hypermobility
The relationship between CFS and hypermobility is unclear, 
with two relatively small studies providing conflicting 
results.44,45
Differences to adult CFS/ME
Children under 12 years old are less likely to describe cog-
nitive problems or problems sleeping compared to adults. 
But they are more likely to complain of sore throats.2 The 
symptom of post-exertional malaise is less often reported in 
this younger age group, but this may be an issue in under-
standing what post-exertional malaise is in younger children. 
Adolescents are more likely to have headaches compared 
with adults and less likely to have pain, tender lymph nodes, 
palpitations, dizziness, and general malaise.2
The most interesting difference and the most important 
issue to highlight to parents (particularly those with CFS 
themselves) is that adolescents are more likely to improve 
and recover compared with adults. Most pediatric studies 
report significant improvement or recovery in between 54% 
and 94% of those treated.46 In the largest pediatric trial to 
date, 75% of children were attending full-time school at 6 
months and 63% were considered recovered on both primary 
and secondary outcomes, which included answering “yes” 
on self-rated “I have completely recovered” or “I feel much 
better but still experience some symptoms”. This compares 
with much lower recovery rates in adults.47 The reasons for 
this difference are unknown but likely to be multifactorial.
The complexities of CFS/ME
CFS is not one homogenous illness. In adults, 3–5 different 
phenotypes (clusters of symptoms) have been described.1,48–52 
Phenotypes can include observational data (e.g., body mass 
index) as well as self-reported symptoms.53 In children, three 
phenotypes have been described54 that are associated with 
markers of severity, but it is not yet known if they predict 
outcome. Two studies1,55 have replicated findings and there 
is some consistency in that most studies describe a poly-
symptomatic phenotype, a sore throat and painful lymph node 
phenotype, and a musculoskeletal pain phenotype.
CFS is also complicated by the association with comor-
bid conditions. These include fibromyalgia, irritable bowel 
syndrome, migraine, and mood disorders. Some of these may 
be secondary to the illness (e.g., anxiety and depression), but 
some are commonly associated with CFS and may represent 
common causality, overlapping symptoms, and therefore 
 difficulty with diagnosis or different care pathways.
Treatment and research are further complicated by the 
range of severity experienced by patients with CFS. While 
all patients must be significantly impaired before being 
diagnosed with CFS, some can attend school full time (but 
do nothing else outside school) while others are unable to 
get out of bed. Few research studies have been conducted in 
patients who are severely affected, and little is known about 
effective treatments in this patient group.
Diagnosis and treatment
The diagnosis of CFS relies on the typical clinical presenta-
tion and the exclusion of other causes of fatigue. A diagnosis 
can be made by taking a thorough history, examining the 
patient, and using blood tests to screen for other causes of 
fatigue.56,57 Assessment should include an assessment of 
mood disorders. These can be co-morbid (exist alongside 
a diagnosis of CFS) or be the primary cause of the fatigue 
which would exclude a diagnosis of CFS. Clinical assessment 
may also identify other areas that require further investigation 
(e.g., imaging if the child has persistent headaches). Treat-
ment can start while investigations continue.56
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Systematic reviews have consistently shown that the 
best evidence for treatment benefit in adults is Cognitive 
Behavioral Therapy (CBT) and Graded Exercise Therapy 
(GET).58–60 The situation is less clear in children.61,62 There 
are five randomized controlled trials that demonstrate benefit 
for children with CFS using CBT. One small pilot study63 
(n=22) investigated the effectiveness of Graded Aerobic 
Exercise therapy compared with progressive resistance train-
ing. While this trial reported benefits in quality of life and 
physical capacity in both arms, it was not powered to test 
differential effectiveness between treatments. While Activity 
Management is a recommended treatment approach in the 
UK,56 there are no trials for testing its efficacy in children.
CBT, GET, and Activity Management all include behav-
ioral approaches to help children and adolescents improve 
their sleep and regulate their activity. Activity Management 
aims to help children and adolescents manage all activities 
and GET focusses on physical activity. CBT uses both a 
behavioral approach for activity and sleep, and a cognitive 
approach to challenge unhelpful thoughts, assumptions, 
and beliefs about, for example, the meaning of symptoms.64 
Advice on sleep includes setting consistent wake-up times, 
reducing excessive sleep to improve sleep quality, and limit-
ing daytime sleep to improve nighttime sleep. This should 
improve sleep and return the disordered diurnal variation in 
cortisol seen in adolescents with CFS65 back to normal.66 
Strategies to improve exercise and activity are based on 
changing a boom–bust pattern of exercise, to a stable baseline 
of activity and exercise. This usually means that children and 
adolescents reduce exercise on good days in the short term. 
This reduces post-exertional malaise (or payback). Once 
activity/exercise is stable, they can steadily increase activity 
or exercise over time.56
Pain
Significant chronic pain is common in pediatric CFS, with 
9%–20% of patients experiencing pain ratings of 75/100 or 
4/4 on Likert scales.2 Most trials in adults with CFS suggest 
that pain is a poor prognostic factor but there is currently 
no evidence on the best method for treating pain in patients 
with CFS. The pain experienced in CFS is very similar to, 
and can be treated as, chronic pain. Clinicians can consider 
referral to a specialist pain management clinic and can con-
sider medical treatment used for chronic pain. Some children 
seem to find amitriptyline helpful, although no trials have 
tested this in children. Amitriptyline should be started at a 
low dose and increased slowly. Some of the side effects of 
amitriptyline such as drowsiness can be helpful for those 
with pain and sleep problems; however, other children find 
that amitriptyline increases their fatigue. Opiates should not 
be prescribed to children with CFS/ME and chronic pain 
because of side effects.
Nausea and eating disorders
Approximately 40% of children with CFS experience sig-
nificant nausea2 and many develop subsequent problems 
with eating. CFS and eating difficulties can develop into a 
vicious cycle where not eating makes the fatigue worse and 
the fatigue and nausea make eating difficult.67 Adolescents 
say that their eating difficulties are caused by abdominal 
pain, being tired, and changes in their sense of taste and 
smell.67 There are no trials for investigating what treatments 
are effective, but current guidance56 suggests that eating little 
and often can be helpful.
While some children struggle to eat because of nausea, 
in others, increasing weight (presumably due to decreased 
activity) is a problem. Children with CFS assessed in a spe-
cialist clinic were found to be at a greater risk of developing 
obesity compared with healthy children (OR 2.31 at 13 years 
and 4.07 at 16 years).68 No increased risk was found in those 
identified as having chronic disabling fatigue in a birth cohort, 
suggesting the risk of developing obesity is only present for 
children and adolescents with CFS that require specialist care.
Cognitive problems
The majority of children (86.7% of adolescents and 76.5% 
of primary school children) complain of cognitive (memory 
and concentration) problems that are frequently described as 
brain fog.2 Two relatively small studies have shown different 
problems with attention, which may be due to the different 
methods of assessment as well as the small sample size.69,70 
One demonstrated problems with sustained attention, switch-
ing attention, divided attention, auditory learning, and imme-
diate recall compared with healthy children, and the other 
described problems with alternative attention and not divided 
or sustained attention. Children often report being fatigued 
by school work and this is consistent with one imaging study 
in children with CFS, which described increased frontal 
activation in Japanese children with CFS while performing 
a dual verbal task to assess divided attention. This suggests 
that the brain may require increased recruitment (cognitive 
compensation) to compensate for poorer task performance.71 
Some of the abnormalities improved as children’s fatigue 
improved after CBT; however, this is only one small study 
and the results need to be replicated.71 General strategies to 
help children with attention difficulties may be helpful and 
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include attention process training, working on the school 
environment to help children maintain attention, as well as 
strategies to improve memory, including overviews, slowing 
the pace of new information, and providing verbal informa-
tion with visual prompts.57,72
Dizziness and orthostatic symptoms
Forty-three percent of primary school children and 30% of 
adolescents experience dizziness as a significant symptom 
and may faint when standing or have an increase in symptoms 
after hot baths. Treatment should start with behavioral meth-
ods, including increasing activity and movement, increasing 
fluid intake to 2–3 L a day, and increasing salt intake.57 Occa-
sionally, medication can be used depending on the response 
to behavioral approaches and the symptoms described.57
Comorbid mood disorders
There is no evidence for the best methods to treat comorbid 
mood disorders in pediatric CFS. While current guidance 
suggests that they should be treated following normal clinical 
practice for low mood and anxiety, this may be in conflict 
with the approach for CFS. CBT for depression and CBT for 
CFS have similarities but also differences.64 The differences 
include the formulation of the problem, the therapeutic goals 
and the impact, and the use of activity and the cognitive 
focus.64 It is the differences in the impact and use of activ-
ity that may determine different treatment approaches. For 
example, patients with CFS are usually advised to do the 
same activities every day and then to gradually increase them. 
At the start, this will mean that they decrease activities and 
exercise on good days to avoid post-exertional malaise (or 
payback). This may conflict with treatment for depression 
where doing an enjoyable activity may be more important 
than limiting exercise.
Conclusion
Pediatricians need to remember that pediatric CFS is com-
mon but treatable. The diagnosis may be harder in primary 
school children as it may present differently from CFS in 
adolescents. Response to treatment is better than in adults, 
and children and adolescents deserve to be offered the range 
of treatment currently available.
Problems with current research
Research into this important illness is hampered by small 
sample sizes, different definitions, and the lack of a coordi-
nated approach. CFS is probably not one illness, and it is likely 
that the different phenotypes are due to different underlying 
biological pathways requiring different treatment approaches. 
This may explain the relatively low response rate to current 
treatments. To develop better treatments, we need larger trials 
with carefully characterized participants to understand more 
about treatment response. We need to develop treatments in 
the areas identified previously where there is no evidence for 
effective treatment. This includes the treatment of CFS and 
comorbid mood disorders, CFS in primary school children, 
those who are severely affected, and those with refractory 
fatigue. We also need to start to develop an understanding 
of the biology of CFS/ME and whether different biological 
pathways are associated with different disease phenotypes. 
Some early studies with small sample studies suggest that an 
omic approach to dissecting out the different subtypes may 
help to clarify different biological pathways.73 This approach 
will require a large bioresource of well-characterized patients.
Disclosure
Prof Crawley is an unpaid medical advisor for the Sussex 
and Kent ME/CFS society.
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